| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis
|
van Wesemael, T J
|
|
|
4 |
5 |
p. e316-e317
|
artikel
|
| 2 |
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study
|
Pfeifer, Jochen
|
|
|
4 |
5 |
p. e329-e337
|
artikel
|
| 3 |
Bilateral linear scleroderma with transition into progressive facial hemiatrophy
|
Kreuter, Alexander
|
|
|
4 |
5 |
p. e374
|
artikel
|
| 4 |
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
|
Boekel, Laura
|
|
|
4 |
5 |
p. e310-e313
|
artikel
|
| 5 |
Evaluation of supported self-management in gout (GoutSMART): a randomised controlled feasibility trial
|
Riches, Philip L
|
|
|
4 |
5 |
p. e320-e328
|
artikel
|
| 6 |
Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal
|
Connolly, Caoilfhionn M
|
|
|
4 |
5 |
p. e307-e308
|
artikel
|
| 7 |
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
|
Wieske, Luuk
|
|
|
4 |
5 |
p. e338-e350
|
artikel
|
| 8 |
IL-1 receptor antagonist, MIS-C, and the peculiar autoimmunity of SARS-CoV-2
|
Bassiri, Hamid
|
|
|
4 |
5 |
p. e305-e307
|
artikel
|
| 9 |
Latika Gupta: a thinker and a doer for myositis research
|
Morgan, Jules
|
|
|
4 |
5 |
p. e319
|
artikel
|
| 10 |
Making inroads on sex and gender
|
The Lancet Rheumatology,
|
|
|
4 |
5 |
p. e303
|
artikel
|
| 11 |
Monoclonal gammopathy of clinical significance: what the rheumatologist needs to know
|
Marinkovic, Angelina
|
|
|
4 |
5 |
p. e362-e373
|
artikel
|
| 12 |
No perfect therapy for the imperfect COVID-19 cytokine storm
|
Cron, Randy Q
|
|
|
4 |
5 |
p. e308-e310
|
artikel
|
| 13 |
Research in Brief
|
Thorley, Jennifer
|
|
|
4 |
5 |
p. e318
|
artikel
|
| 14 |
Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Han, MeiLan K
|
|
|
4 |
5 |
p. e351-e361
|
artikel
|
| 15 |
Self-management of gout using a mobile app
|
Stamp, Lisa K
|
|
|
4 |
5 |
p. e304-e305
|
artikel
|
| 16 |
The changing face of psoriatic arthritis
|
Aydin, Sibel Z
|
|
|
4 |
5 |
p. e313-e315
|
artikel
|
Tijdschrift beschrijving